The invention concerns new compositions comprising an antagonist of aldosterone administered according to a prescribed dosage for the treatment of insufficiency cardiac mammalian animals non-human.L'inventionconcerne de nouvellescompositions comprenant un antagonistede l'aldostérone administrées selonune posologie prescrite pour letraitement de l'insuffisancecardiaque des animaux mammifèresnon humains.